Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.
Nicklin
Jim
J
Perrin
Lewis
L
Crandon
Alex
A
Land
Russell
R
Nascimento
Marcelo
M
Obermair
Andreas
A
D000465:Algorithms; D001315:Australia; D003029:Coagulants / Q000627:therapeutic use*; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011994:Recombinant Proteins / Q000627:therapeutic use
D003029:Coagulants; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa